To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects

JW Pharmaceutical

Status and phase: Active, not recruiting; Phase 1

Conditions: Healthy Male Adults

Treatments: Drug: 14C Epaminurad Oral Solution

Study type: Interventional

Funder types: Industry

Identifiers

NCT07036458

JW24104

Details and patient eligibility

About

To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects

Full description

The following blood, urine and faecal samples will be collected, and assessments performed, at specified time points

Enrollment: 8 estimated patients

Sex: Male

Ages: 30 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Healthy volunteers

Exclusion criteria

1. Subjects does not meet the Inclusion Criteria

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

8 participants in 1 patient group

Subjects will receive a single administration of 14C Epaminurad Oral Solution

Other group

Treatment:

Drug: 14C Epaminurad Oral Solution